Related Experiment Video

Updated: Jul 19, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Melanoma pathogenesis and Nodal: a partial picture?

David S Salomon

    Nature Medicine
    |November 8, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    Related Experiment Videos

    Last Updated: Jul 19, 2026

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    Related Concept Videos

    Skin Cancer01:30

    Skin Cancer

    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

    Articles linked to this work by shared authors, journal, and citation graph.

    Spatiotemporal modulation of growth factors directs the generation of multilineage mouse embryonic stem cell-derived mammary organoids.

    Developmental cell·2023

    Cancer stem cells as the source of tumor associated myoepithelial cells in the tumor microenvironment developing ductal carcinoma in situ.

    Biomaterials·2023

    GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation.

    Cytotechnology·2023

    Optimization of production and characterization of a recombinant soluble human Cripto-1 protein inhibiting self-renewal of cancer stem cells.

    Journal of cellular biochemistry·2022

    Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways.

    Journal of experimental & clinical cancer research : CR·2022

    Whence CRIPTO: The Reemergence of an Oncofetal Factor in 'Wounds' That Fail to Heal.

    International journal of molecular sciences·2021

    Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.

    Nature medicine·2026

    Oligonucleotide-siRNA conjugate for SOD1 amyotrophic lateral sclerosis: a phase 1 trial.

    Nature medicine·2026

    An anti-PMEL antibody-drug conjugate with a G<sub>q/1</sub><sub>1</sub> inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

    Nature medicine·2026

    Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

    Nature medicine·2026

    Health system learning enables generalist neuroimaging models.

    Nature medicine·2026

    KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRAS<sup>G12D</sup>-mutant pancreatic cancer: a phase 1b/2 trial.

    Nature medicine·2026

    Fluoroquinolone-resistant <i>Salmonella Typhi</i> presenting as ileal perforation in a traveler.

    Journal of surgical case reports·2026

    Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia.

    Haematologica·2026

    Human granulocytic anaplasmosis-associated myopericarditis: a case report and literature review of a treatable cause of myopericarditis.

    Journal of medical case reports·2026

    Pagetoid reticulosis (Woringer-Kolopp disease) mimicking eczema: a case report with immunophenotypic analysis and literature review.

    Frontiers in immunology·2026

    [Pleural Well-differentiated Papillary Mesothelial Tumor Presenting with 
Recurrent Pneumothorax and Pleural Effusion: A Case Report].

    Zhongguo fei ai za zhi = Chinese journal of lung cancer·2026

    Anthracofibrosis: an under-recognised mimic of malignancy and tuberculosis in a migrant population.

    Internal medicine journal·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us